Kaanapali Land 3Q 2026: Revenue $731K, EPS $0.04 — 10-Q Summary

Kaanapali Land reported 3Q 2026 revenue of $731K, up 56.5% YoY, and net income of $71K, reversing a prior-year loss. EPS turned positive at $0.04. The company sold 21 acres for $19.9M and received $857K in insurance proceeds. Development plans include agricultural lots and a 940-unit village project.

Original reporting
Published Nov 12, 2026, 8:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 8:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Kaanapali Land 3Q 2026: Revenue $731K, EPS $0.04 — 10-Q Summary — source image
Decision brief

The 30-second read

Low
01

Why it matters

The company turned profitable for the quarter, driven by insurance recoveries and a recent land sale.

02

Market read

Micro‑cap earnings release with modest numbers; limited trading relevance.

03

What to watch

Potential exposure to wildfire risk and reliance on insurance recoveries.

Relevance 5/10Novelty 4/10Timing: post-market today

Background

Kaanapali Land LLC filed its 10‑Q for Q3 2026, reporting a revenue increase to $731K and a small profit of $71K.

Market effects

Limited impact; small-cap real estate earnings update.

Minor effect on regional real estate investors.

Negligible.

Counterpoint

The earnings beat may be outweighed by the company's small scale and limited liquidity.

Key entities

  • Kaanapali Land LLC

    Micro‑cap real estate firm reporting Q3 2026 results.

Related articles

$ZTEKFMed

Zentek Ltd. (ZTEKF): Financial results for FY2027

Zentek Ltd. (ZTEKF) furnished an SEC Form 6-K — earnings release. Zentek Q2 Fiscal 2027 Results News Release Zentek Strengthens Its Balance Sheet, Ends Second Quarter with $13.6 Million in Cash Working capital of $11.3 million at September 30, 2026, compared with a deficit of $1.3 million at March 31, 2026 Guelph, Ontario, November 16, 2026. Ze

$WBMedAI 8/10

Alibaba Is Pulling Back From This 10% Dividend Stock

Weibo (WB) missed Q3 revenue and earnings expectations, with advertising revenue from Alibaba (BABA) falling 33%. Shares dropped 4% premarket. GAAP net income fell 88.91%, operating cash flow turned negative, and long-term loans were reclassified as current. The dividend yield is 10.6%, but earnings are declining. CEO Gaofei Wang highlighted AI efforts, but ad budgets remain a concern.

$SLSHighAI 9/10

SELLAS Gets A REGAL Boost As Immunotherapeutic Cancer Vaccine Trial Meets Primary Endpoint

SELLAS Life Sciences (SLS) reported positive Phase 3 REGAL trial results for its cancer vaccine, Galinpepimut-S (GPS), meeting the primary endpoint of overall survival. GPS reduced the risk of death by 41% compared to standard treatment, with median OS of 24.0 months vs. 14.7 months. The company plans to discuss an accelerated FDA filing pathway and aims for a BLA submission in early 2027. Shares surged over 255% in premarket trading.